Last updated on 5 May 2023
Owner Info
Allogene Therapeutics, Inc.
210 E. Grand Avenue
South San Francisco CA 94080, UNITED STATES OF AMERICA
Serial Number
2004343 filed on 14 Mar 2019
Correspondent
Jason S. Howell Perkins Coie LLP
1201 Third Avenue, Suite 4900,
Seattle WA 98101,
UNITED STATES OF AMERICA
2004343
NA
NA
WORD
18 Sept 2018
US
Status Date | Action Taken |
---|---|
5th May 2023 | Status change to Voided |
13th Jan 2023 | International Registration in Australia Refused correspondence sent |
11th Jan 2023 | Status change to Lapsed/Not Protected |
10th Jan 2023 | Refused to Grant Extension of Time correspondence sent |
16th Dec 2022 | Intention to Refuse to Grant an Extension of Time correspondence sent |
9th Nov 2022 | Adverse Report (Extension of Time) correspondence sent |
8th Nov 2022 | Adverse Issues Response Received |
7th Nov 2022 | General Request Initiated |
5th Oct 2022 | General Correspondence sent |
5th Oct 2022 | Adverse Report (Extension of Time) correspondence sent |